TAF + Emtricitabine + Darunavir + Cobicistat
Form: Tablet
Strength: Darunavir- 800 mg + Cobicistat-1 50 mg + Emtricitabine- 200 mg + TAF-10 mg
Reference Brands: Symtuza(Eu & US)
Category: Anti Viral
Symtuza is the first once-daily, single-tablet regimen combining Darunavir 800 mg, Cobicistat 150 mg, Emtricitabine 200 mg, and Tenofovir Alafenamide (TAF) 10 mg for the treatment of HIV-1 infection. Approved by both the FDA and EMA, Symtuza is indicated for adults and adolescents (≥12 years, ≥40 kg) who are treatment-naïve or virologically suppressed. The high resistance barrier of Darunavir, boosted by Cobicistat, makes Symtuza ideal for durable viral suppression. Its TAF backbone ensures better renal and bone safety than older TDF-based regimens. Symtuza offers the simplicity of a PI-based single-tablet regimen, enhancing long-term adherence.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Zanamivir
Strength: 5 mg/blister
Form: Inhalation powder
Reference Brands: Relenza(EU & US)
View Details Get Enquiry
Oseltamivir Phosphate Capsule
Strength: Capsule- 30 mg, 45 mg, 75 mg; Oral Suspension - 6 mg/mL (reconstituted)
Form: Capsules and Oral solution
Reference Brands: Tamiflu(EU & US)
View Details Get Enquiry
Amantadine
Strength: Tab -100 mg; Capsule- 100 mg; Oral solution - 50 mg/5 mL; Extended-release capsule (ER) - 129 mg, 193 mg
Form: Tablet; Capsule; Oral Solution and ER Capsule
Reference Brands: Symmetrel(EU & US); Osmolex ER(US), Gocovri(US)
View Details Get Enquiry
Glecaprevir + Pibrentasvir
Strength: Glecaprevir- 100 mg + Pibrentasvir - 40 mg
Form: Tablet
Reference Brands: Mavyret (US); Maviret (EU)
View Details Get Enquiry